JAMES DALTON: Open Payments
NPI 1790788180 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 15 payments from 8 companies in 2025. Trend: 2023 $487 · 2024 $605 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $34 |
| Dexcom, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: LEQVIO, Kerendia, DUPIXENT, Wegovy, Dexcom G6 Transmitter, Korlym, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
